Qilian International Holding Group Limited (BGM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Qilian International Holding Group Limited (BGM) has a cash flow conversion efficiency ratio of -0.017x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.06 Million) by net assets ($183.49 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Qilian International Holding Group Limited - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Qilian International Holding Group Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Qilian International Holding Group Limit for a breakdown of total debt and financial obligations.
Qilian International Holding Group Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Qilian International Holding Group Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Leading Edge Materials Corp
V:LEM
|
-0.032x |
|
MCE Holdings Bhd
KLSE:7004
|
0.008x |
|
Finetechnix. Co.Ltd
KQ:106240
|
0.015x |
|
REDCO PRP GROUP LTD -05
F:8KI
|
N/A |
|
ABO Group
BR:ABO
|
0.158x |
|
Cheil Grinding
KO:001560
|
0.025x |
|
Aplisens SA
WAR:APN
|
0.047x |
|
DocGo Inc
NASDAQ:DCGO
|
-0.083x |
Annual Cash Flow Conversion Efficiency for Qilian International Holding Group Limited (2017–2024)
The table below shows the annual cash flow conversion efficiency of Qilian International Holding Group Limited from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see Qilian International Holding Group Limit (BGM) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-09-30 | $44.09 Million | $544.24K | 0.012x | +75.34% |
| 2023-09-30 | $44.35 Million | $312.21K | 0.007x | -96.94% |
| 2022-09-30 | $54.96 Million | $12.65 Million | 0.230x | +3681.28% |
| 2021-09-30 | $56.67 Million | $345.03K | 0.006x | -96.54% |
| 2020-09-30 | $28.84 Million | $5.08 Million | 0.176x | +786.70% |
| 2019-09-30 | $22.64 Million | $-580.20K | -0.026x | -110.23% |
| 2018-09-30 | $17.72 Million | $4.44 Million | 0.250x | +27.54% |
| 2017-09-30 | $13.66 Million | $2.68 Million | 0.196x | -- |
About Qilian International Holding Group Limited
BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline active pharmaceutical ingredients, which are used by pharmaceutical companies in the manufactu… Read more